BMNDF
Price:
$0.7
Market Cap:
$54.27M
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating i...[Read more]
Industry
Biotechnology
IPO Date
2021-07-27
Stock Exchange
PNK
Ticker
BMNDF
According to Biomind Labs Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -70.00. This represents a change of -14.92% compared to the average of -82.27 of the last 4 quarters.
The mean historical PE Ratio of Biomind Labs Inc. over the last ten years is -17.03. The current -70.00 PE Ratio has changed 41.01% with respect to the historical average. Over the past ten years (40 quarters), BMNDF's PE Ratio was at its highest in in the December 2023 quarter at -6.69. The PE Ratio was at its lowest in in the September 2024 quarter at -280.46.
Average
-17.03
Median
-11.60
Minimum
-60.26
Maximum
-2.03
Discovering the peaks and valleys of Biomind Labs Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 224.76%
Maximum Annual PE Ratio = -2.03
Minimum Annual Increase = -82.48%
Minimum Annual PE Ratio = -60.26
Year | PE Ratio | Change |
---|---|---|
2023 | -6.16 | -32.83% |
2022 | -9.17 | -48.50% |
2021 | -17.80 | 40.97% |
2020 | -12.63 | 91.32% |
2019 | -6.60 | 224.76% |
2018 | -2.03 | -82.48% |
2017 | -11.60 | -80.75% |
2016 | -60.26 | 123.19% |
The current PE Ratio of Biomind Labs Inc. (BMNDF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-11.04
5-year avg
-10.47
10-year avg
-17.03
Biomind Labs Inc.’s PE Ratio is less than Cellectis S.A. (-3.72), less than Biotron Limited (-1.41), less than Small Pharma Inc. (-2.18), less than Bioasis Technologies Inc. (0), less than Covalon Technologies Ltd. (16.11), less than Moolec Science SA (-40.28), less than Mindset Pharma Inc. (-4.00), less than America Great Health (-43.28), less than Mind Cure Health Inc. (-4.66), less than Janux Therapeutics, Inc. (-19.69), less than Wesana Health Holdings Inc. (-0.67), less than BioVaxys Technology Corp. (-1.66), less than GH Research PLC (-16.25), less than Algernon Pharmaceuticals Inc. (8.62), less than AXIM Biotechnologies, Inc. (-0.64), less than Antibe Therapeutics Inc. (-1.04), less than Arch Therapeutics, Inc. (-0.00), less than Awakn Life Sciences Corp. (-1.27),
Company | PE Ratio | Market cap |
---|---|---|
-3.72 | $90.12M | |
-1.41 | $12.61M | |
-2.18 | $37.51M | |
0 | $288.90K | |
16.11 | $55.38M | |
-40.28 | $34.35M | |
-4.00 | $54.51M | |
-43.28 | $40.29M | |
-4.66 | $86.53M | |
-19.69 | $1.47B | |
-0.67 | $466.32K | |
-1.66 | $9.04M | |
-16.25 | $731.31M | |
8.62 | $1.73M | |
-0.64 | $2.11M | |
-1.04 | $11.43M | |
-0.00 | $444.00 | |
-1.27 | $2.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biomind Labs Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biomind Labs Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biomind Labs Inc.'s PE Ratio?
How is the PE Ratio calculated for Biomind Labs Inc. (BMNDF)?
What is the highest PE Ratio for Biomind Labs Inc. (BMNDF)?
What is the 3-year average PE Ratio for Biomind Labs Inc. (BMNDF)?
What is the 5-year average PE Ratio for Biomind Labs Inc. (BMNDF)?
How does the current PE Ratio for Biomind Labs Inc. (BMNDF) compare to its historical average?